Up-regulation of IRF-3 expression through GATA-1 acetylation by histone deacetylase inhibitor in lung adenocarcinoma A549 cells

Interferon regulatory factor 3 (IRF-3) is an important transcription factor for interferon genes. Although its functional activation by viral infection has been widely explicated, the regulatory mechanism of IRF-3 gene expression in cancer cells is poorly understood. In this study, we demonstrated treatment of lung adenocarcinoma A549 cells with trichostatin A (TSA) and valproic acid (VPA), two different classes of histone deacetylase inhibitors, strongly stimulated IRF-3 gene expression. Truncated and mutated IRF-3 promoter indicated that a specific GATA-1 element was responsible for TSA-induced activation of IRF-3 promoter. Chromatin immunoprecipitation and electrophoretic mobility shift assay showed that TSA treatment increased the binding affinity of GATA-1 to IRF-3 promoter. Using immunoprecipitation assay and immunoblotting, we demonstrated that TSA increased the level of acetylated GATA-1 in A549 cells. In summary, our study implied that TSA enhanced IRF-3 gene expression through increased GATA-1 recruitment to IRF-3 promoter and the acetylation level of GATA-1 in lung adenocarcinoma A549 cells.

[1]  A. Ikari,et al.  Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells* , 2017, The Journal of Biological Chemistry.

[2]  Divya Mahajan,et al.  Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells , 2016, Oncotarget.

[3]  Kol Jia Yong,et al.  Targeting SALL4 by entinostat in lung cancer , 2016, Oncotarget.

[4]  Lei Zhou,et al.  The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer , 2016, Oncotarget.

[5]  J. Hiscott,et al.  The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation , 2015, Oncogene.

[6]  Yanshu Li,et al.  GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling , 2015, Oncotarget.

[7]  T. Homma,et al.  Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3 , 2014, Scientific Reports.

[8]  Weiwei Zheng,et al.  EDAG Positively Regulates Erythroid Differentiation and Modifies GATA1 Acetylation Through Recruiting p300 , 2014, Stem cells.

[9]  S. Leng,et al.  GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  P. Zhang,et al.  PML4 facilitates erythroid differentiation by enhancing the transcriptional activity of GATA-1. , 2014, Blood.

[11]  Dan Sun,et al.  HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells , 2013, PloS one.

[12]  Yi Wang,et al.  Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. , 2012, Biochimie.

[13]  Kirby D. Johnson,et al.  Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies , 2012, Nucleic acids research.

[14]  F. Liang,et al.  Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells. , 2012, The international journal of biochemistry & cell biology.

[15]  R. Hardison,et al.  Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes , 2011, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Yatabe,et al.  Aberrant expression of interferon regulatory factor 3 in human lung cancer. , 2010, Biochemical and biophysical research communications.

[17]  Chao Lu,et al.  Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1 , 2010, Molecular Biology Reports.

[18]  Yanyan Zhao,et al.  Upregulation of human with-no-lysine kinase-4 gene expression by GATA-1 acetylation. , 2009, The international journal of biochemistry & cell biology.

[19]  E. Van Cutsem,et al.  Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer , 2008, Investigational New Drugs.

[20]  L. Chin,et al.  Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. , 2007, Cancer research.

[21]  Y. Miyagi,et al.  Genome-wide cDNA microarray screening of genes related to survival in patients after curative resection of non-small cell lung cancer. , 2006, Oncology reports.

[22]  K. Venkatasubbarao,et al.  Trichostatin A Induces Transforming Growth Factor β Type II Receptor Promoter Activity and Acetylation of Sp1 by Recruitment of PCAF/p300 to a Sp1·NF-Y Complex* , 2005, Journal of Biological Chemistry.

[23]  Edward Gabrielson,et al.  Hypermethylation of the GATA Genes in Lung Cancer , 2004, Clinical Cancer Research.

[24]  J. Nemunaitis,et al.  Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors , 2004, Cancer investigation.

[25]  T. Naoe,et al.  Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation , 2003, Oncogene.

[26]  J. Yim,et al.  Oncogenic Potential of a Dominant Negative Mutant of Interferon Regulatory Factor 3* , 2003, The Journal of Biological Chemistry.

[27]  J. Hiscott,et al.  In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors. , 2002, Cancer research.

[28]  G. Blobel,et al.  CREB-Binding Protein Acetylates Hematopoietic Transcription Factor GATA-1 at Functionally Important Sites , 1999, Molecular and Cellular Biology.

[29]  S. Orkin,et al.  Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. , 1999, Molecular cell.

[30]  V. Ogryzko,et al.  Regulation of activity of the transcription factor GATA-1 by acetylation , 1998, Nature.

[31]  C. Noguchi,et al.  Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. , 1995, Nucleic acids research.